Pentasa 500 mg Extended Release Oral Capsule
RxNorm 580286
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 580286 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Pentasa 500 mg Extended Release Oral Capsule.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBDPrescribable
Semantic Branded Drug (SBD):
Mesalamine 500 mg Extended Release Oral Capsule [Pentasa]
(Atom ID: 6349063)
PSNPrescribable
Prescribable Name (PSN):
Pentasa 500 mg Extended Release Oral Capsule
(Atom ID: 6367108)
SYPrescribable
Synonym (SY):
Pentasa 500 mg Extended Release Oral Capsule
(Atom ID: 6356487)
Patient Education
Mesalamine
Mesalamine is used to treat ulcerative colitis (a condition which causes swelling and sores in the lining of the colon [large intestine] and rectum) and also to maintain improvement of ulcerative colitis symptoms. Mesalamine is in a class of medications called anti-inflammatory agents. It works by stopping the body from producing a certain substance that may cause inflammation.
[Learn More]
* Please review the disclaimer below.